New Jersey S 4222: Improves access to lower-cost generic and biosimilar drugs.

Status: Introduced in the Senate, Referred to Senate Commerce Committee (as of 2026-05-14)

State: New Jersey · Session: 222 · Bill: S 4222

Sponsors: Johnson, Gordon M.

View New Jersey S 4222 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.